Raman Spectroscopy for Prostate Tumor Aggressiveness Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing prostate tumors, particularly in biopsy specimens, are time-consuming, expensive, and often insufficiently objective, especially when differentiating between aggressive and non-aggressive tumors, especially in small tumors where tissue samples may contain non-representative tissue.

Innovation Solution

Raman spectroscopy is used to analyze samples, such as tissue sections or biopsy specimens, to objectively determine the presence of aggressive or non-aggressive prostate tumors by evaluating Raman spectra, which can include biomarkers, and comparing them to reference spectra to assess tumor aggressiveness and staging.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional analysis methods are used for biopsy specimens, then the analysis can be performed with existing equipment and protocols, but the analysis is time-consuming, expensive, and often insufficiently objective

Engineering Contradiction:
Improveobjectivity of tumor differentiationVSAvoidanalysis time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent replaces conventional mechanical/histological analysis methods with Raman spectroscopy, an optical measurement technique. This substitution enables objective, quantitative analysis of tissue samples through spectral fingerprinting, eliminating the time-consuming and subjective nature of traditional pathological examination while maintaining or improving diagnostic reliability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent transforms the analysis from qualitative histological parameters to quantitative spectral parameters. By measuring Raman shift values, intensity ratios, and spectral fingerprints, the method converts subjective visual assessment into objective numerical data that can be automatically evaluated, thereby reducing analysis time and improving reproducibility.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If conventional analysis methods are used for small prostate tumors, then the analysis can be performed on available tissue samples, but the specimens may contain only non-representative tissue located far from the tumor

Engineering Contradiction:
Improvedetection accuracy of tumor aggressivenessVSAvoidrepresentativeness of tissue sample
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent uses Raman spectroscopy as an intermediary technique that can detect molecular signatures of tumor aggressiveness in tissue samples even when the sampling location is not optimal. The spectral analysis acts as a mediator that identifies biomolecular patterns (such as protein, lipid, and nucleic acid compositions) characteristic of aggressive tumors, allowing accurate detection despite the presence of non-representative tissue.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The method changes from relying on morphological parameters (which require representative tissue architecture) to molecular spectral parameters. By analyzing the Raman spectrum for biochemical fingerprints of tumor markers, the system can detect aggressive tumor characteristics even in limited or non-ideal tissue samples, thereby maintaining high detection accuracy.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If conventional analysis methods are used, then the analysis can be performed with standard equipment, but the methods are expensive and insufficiently objective for determining tumor aggressiveness

Engineering Contradiction:
Improveobjectivity of tumor classificationVSAvoidequipment requirements
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent replaces complex, expensive conventional histological analysis equipment with a Raman spectroscopy system. While Raman spectroscopy requires specialized equipment, the method simplifies the analysis process through automated spectral acquisition and evaluation, reducing the need for complex manual processing and expert pathologist interpretation, thereby improving objectivity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

4Measurement precision

If Raman spectroscopy is used to analyze samples, then objective and quantitative analysis of prostate tumors is enabled, but the method requires specialized equipment and expertise

Engineering Contradiction:
Improvequantitative measurement of tumor characteristicsVSAvoidRaman spectroscopy system requirements
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent creates a digital copy of the tissue sample's molecular fingerprint through Raman spectroscopy. By acquiring the complete Raman spectrum and storing it as data, the system enables objective, quantitative analysis without requiring physical manipulation or complex processing of the actual tissue. This digital copying approach simplifies the measurement process while maintaining high precision.

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for the objective and quantitative analysis of prostate tumors, enabling the differentiation between aggressive and non-aggressive tumors, even in cases where conventional methods are inconclusive, and provides insights into tumor staging and aggressiveness without the need for individual biomarker assignment.

Implementation Method 1

Raman spectroscopy is carried out in order to analyze a sample. One or a plurality of Raman spectra can be analyzed

Methodology Applied
Scientific EffectRaman scattering: Scattering

Data Source

PatentUS9903869B2Device and method for analyzing a sample for the identification of prostate tumours
Publication Date: 2018.02.27 CELLTOOL GMBH
  • US9903869B2 patent drawing
  • US9903869B2 patent drawing
  • US9903869B2 patent drawing

AI summary

In order to identify a prostate tumor with a Raman spectroscopy system, at least one Raman spectrum (40) of a sample is detected. The at least one Raman spectrum (40) is evaluated in order to identify a prostate tumor and/or distinguish an aggressive from a non-aggressive prostate tumor based on a characteristic pattern in the at least one Raman spectrum (40).